TIMP1 and lung cancer: Moreover, meta-analysis of clinical data from publicly available databases (TCGA database) of LUAD in this study supports TIMP-1 being an important potential biomarker in lung cancer, as significantly elevated levels of TIMP-1 are seen in NSCLC tissues in comparison to benign lung tissue.